Skip to main content
B

BIONIME CORPORATION — Investor Relations & Filings

Ticker · 4737 TW Manufacturing
Filings indexed 1,731 across all filing types
Latest filing 2025-10-16 Regulatory Filings
Country TW Taiwan
Listing TW 4737

About BIONIME CORPORATION

https://www.bionime.com

Bionime Corporation is a biotechnology firm specializing in the research, design, and manufacturing of comprehensive blood glucose management systems. The company develops high-precision monitoring solutions for both personal home use and professional medical environments, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). Under its proprietary brand, RIGHTEST, Bionime integrates medical, chemical, electronic, and precision machinery expertise to deliver products that rival international standards. A core component of its offering is a cloud-based management ecosystem powered by IoT digital solutions, which synchronizes medical data with patient care services. With over 480 core patents in CGM technology and a commitment to Industry 4.0 smart production, Bionime focuses on enhancing diabetes care through technical innovation and a human-centered approach to health monitoring.

Recent filings

Filing Released Lang Actions
114年10月變更登記
Regulatory Filings
2025-10-16 Chinese
114年10月僑外投資持股
Regulatory Filings
2025-10-16 Chinese
114年9月背書保證與資金貸與
Regulatory Filings
2025-10-13 Chinese
114年9月營業收入
Regulatory Filings
2025-10-13 Chinese
114年09月內部人持股異動(事後)
Regulatory Filings
2025-10-03 Chinese
114年09月董事會成員及持股
Regulatory Filings
2025-10-03 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.